Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Frontier Medicines

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
2018
101-250
San Francisco, California, United States

Investment Funding

Last Funding Stage

Series C

Total Funding Amount

256.M

Last Funding Amount

20.M

Last Funding Date

25-06-2024

Startup Stage

Late Stage Venture

Lead Investors

Deerfield Management, RA Capital Management, DCVC Bio, Deerfield, MPM Capital

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information